Is MDGL up or down today?
MDGL is up 0.69% today, last at 542.50. This stock moved +0.69% versus the prior close.
MDGL · MDGL
MDGL (MDGL) is trading at 542.50, up 0.69% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 12 headlines skew mixed. Analyst Rating and Earnings themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact +1.40%).
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
MDGL is up 0.69% today, last at 542.50. This stock moved +0.69% versus the prior close.
Over the past 7 days, 12 headlines skew mixed. Analyst Rating and Earnings themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact +1.40%). Dominant story: BlackRock (MDGL holder) discloses 4.6% Madrigal Pharmaceuticals stake in Schedule 13G/A - Stock Titan (3 sources, neutral) RSI is 53 — neutral Price above 50-day average — short-term uptrend Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,567 mentions over 30d
BlackRock (MDGL holder) discloses 4.6% Madrigal Pharmaceuticals stake in Schedule 13G/A - Stock Titan
MDGL Maintained by Canaccord Genuity -- Price Target Raised to $587 - GuruFocus
Madrigal Pharmaceuticals, Inc. Q2 2026 Earnings Preview
Madrigal earnings in focus as Rezdiffra launch accelerates By Investing.com - Investing.com Nigeria
Madrigal earnings in focus as Rezdiffra launch accelerates By Investing.com - Investing.com South Africa